Germany to channel EUR 80 million into stem cell centre
Munster – Germany’s federal state North-Rhine Westfalia is to channel EUR 80million into the medical applications of stem cell research. On Friday, the country’s minister Juergen Ruettgers announced that the money will be used to create a new Center for Advanced Regenerative Engineering (CARE), at Munster, in which top researchers will focus on applications of stem cell research such as drug screening with cells derived from induced pluripotent stem cells.
Such individual human cells provide a new source of disease models that better mimick the processes in the human body than animal cells or models, particularly in drug toxicity screening or medelling of disease mechanisms. Several life science firms including Roche, GE Healthcare and Pfizer are already active in the field. North-Rhine-Westfalia will contribute with 75% of the
funding and the rest will come from by the German Research Ministy.
The Centre will be located at the Max-Planck-Insitute for Molecular
Biomedicine, headed by Germany’s top-stem cell researcher Prof. Hans Schoeler. Schoeler announced that 4 research groups for young investigators will kick-off in the summer of 2010 as part of the funding.